Get started
Indivior Pharmaceuticals, Inc.Indivior Pharmaceuticals, Inc.Indivior Pharmaceuticals, Inc.

Indivior Pharmaceuticals, Inc.

No trades
OverviewFinancialsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFs

Chart


Full chart

Upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪4.42 B‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
34.56
Basic EPS (TTM)
1.02 USD
Net income (FY)
‪2.00 M‬ USD
Revenue (FY)
‪1.19 B‬ USD
Shares float
‪113.11 M‬
Beta (1Y)
0.71

Employees


Employees (FY)
‪1.05 K‬
Change (1Y)
−113 −9.71%
Revenue / Employee (1Y)
‪1.13 M‬ USD
Net income / Employee (1Y)
‪1.90 K‬ USD

About Indivior Pharmaceuticals, Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Joseph J. Ciaffoni
Website
indivior.com
Headquarters
North Chesterfield
Identifiers
3
ISIN US45579U1097
Indivior Pharmaceuticals, Inc. is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company is headquartered in North Chesterfield, VA.

Check out other big names from the same industry as INDV.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

News



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

ETFs holding the stock


IJR
iShares Core S&P Small Cap ETF
Weight
0.28%
Market value
‪263.45 M‬
USD
IWM
iShares Russell 2000 ETF
Weight
0.14%
Market value
‪104.86 M‬
USD
VXF
Vanguard Extended Market ETF
Weight
0.06%
Market value
‪48.25 M‬
USD
SPSM
State Street SPDR Portfolio S&P 600 Small Cap ETF
Weight
0.28%
Market value
‪39.09 M‬
USD
IJT
iShares S&P Small-Cap 600 Growth ETF
Weight
0.56%
Market value
‪36.74 M‬
USD
IWO
iShares Russell 2000 Growth ETF
Weight
0.23%
Market value
‪31.14 M‬
USD
VTWO
Vanguard Russell 2000 ETF
Weight
0.15%
Market value
‪21.39 M‬
USD
SCHA
Schwab U.S. Small-Cap ETF
Weight
0.10%
Market value
‪20.85 M‬
USD
SLYG
State Street SPDR S&P 600 Small Cap Growth ETF
Weight
0.54%
Market value
‪20.22 M‬
USD
VIOO
Vanguard S&P Small-Cap 600 ETF
Weight
0.30%
Market value
‪14.77 M‬
USD
IHE
iShares U.S. Pharmaceuticals ETF
Weight
1.17%
Market value
‪11.35 M‬
USD

Explore more ETFs 

Frequently Asked Questions


The current price of INDV is 35.93 USD — it has increased by 1.93% in the past 24 hours. Watch Indivior Pharmaceuticals, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Indivior Pharmaceuticals, Inc. stocks are traded under the ticker INDV.
INDV stock has risen by 4.99% compared to the previous week, the month change is a −0.90% fall, over the last year Indivior Pharmaceuticals, Inc. has showed a 195.20% increase.
We've gathered analysts' opinions on Indivior Pharmaceuticals, Inc. future price: according to them, INDV price has a max estimate of 50.00 USD and a min estimate of 36.00 USD. Watch INDV chart and read a more detailed Indivior Pharmaceuticals, Inc. stock forecast: see what analysts think of Indivior Pharmaceuticals, Inc. and suggest that you do with its stocks.
INDV reached its all-time high on Dec 8, 2025 with the price of 38.00 USD, and its all-time low was 1.75 USD and was reached on Apr 10, 2019. View more price dynamics on INDV chart.
See other stocks reaching their highest and lowest prices.
INDV stock is 2.24% volatile and has beta coefficient of 0.71. Track Indivior Pharmaceuticals, Inc. stock price on the chart and check out the list of the most volatile stocks — is Indivior Pharmaceuticals, Inc. there?
Today Indivior Pharmaceuticals, Inc. has the market capitalization of ‪4.41 B‬, it has increased by 5.34% over the last week.
Yes, you can track Indivior Pharmaceuticals, Inc. financials in yearly and quarterly reports right on TradingView.
Indivior Pharmaceuticals, Inc. is going to release the next earnings report on Feb 26, 2026. Keep track of upcoming events with our Earnings Calendar.
INDV earnings for the last quarter are 0.72 USD per share, whereas the estimation was 0.41 USD resulting in a 74.90% surprise. The estimated earnings for the next quarter are 0.67 USD per share. See more details about Indivior Pharmaceuticals, Inc. earnings.
Indivior Pharmaceuticals, Inc. revenue for the last quarter amounts to ‪314.00 M‬ USD, despite the estimated figure of ‪261.92 M‬ USD. In the next quarter, revenue is expected to reach ‪305.62 M‬ USD.
INDV net income for the last quarter is ‪42.00 M‬ USD, while the quarter before that showed ‪18.00 M‬ USD of net income which accounts for 133.33% change. Track more Indivior Pharmaceuticals, Inc. financial stats to get the full picture.
No, INDV doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 2, 2026, the company has ‪1.05 K‬ employees. See our rating of the largest employees — is Indivior Pharmaceuticals, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Indivior Pharmaceuticals, Inc. EBITDA is ‪353.04 M‬ USD, and current EBITDA margin is 26.43%. See more stats in Indivior Pharmaceuticals, Inc. financial statements.
Like other stocks, INDV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Indivior Pharmaceuticals, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Indivior Pharmaceuticals, Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Indivior Pharmaceuticals, Inc. stock shows the buy signal. See more of Indivior Pharmaceuticals, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.